09:00 a.m.

10:00 a.m.

•

•

•

ACADEMIC SESSION 3

Prevention of Diabetes and Cardiovascular Disease

R. Paoletti (Italy)

The dietary antioxidant resveratrol and
cardiovascular disease

F. P. Mancini (Italy)

Risk factors and prevention in third millenium

G. Assmann (Germany)

School based strategies for the obesity, diabetes

and cardiovascular prevention

M. Davidson (USA)

10:30 a.m.

11:00 a.m.

Coffee Break

11.00 a.m

11.45 a.m.

•

State of the Art Lecture

Chair: S. Smith (USA)

Can additional biomarkers improve risk prediction in the metabolic syndrome?

W. Koenig (Germany)

11.45 a.m.

12.30 a.m.

•

State of the Art Lecture

Chair : B. Brewer (USA)

Fibrates versus statins in the treatment of
metabolic syndrome and type 2 Diabetes:
lessons from clinical trials

S. Robins (USA)

12:30 p.m.

02:00 p.m.

Lunch

02:00 p.m.

03:30 p.m.

•

•

•

ACADEMIC SESSION 4

Metabolic abnormalities and psychological complications associated with the Metabolic Syndrome and Diabetes

Chair: G. Crepaldi (Italy)

Psychosocial stress and the metabolic syndrome:
pathogenic and therapeutic aspects

A.G. Olsson (Sweden)

Treatment of dyslipidemia, depression and tobacco

dependency in metabolic syndrome

R. Ceska (Czech Republic)

Physical and mental comorbidity associated with

the Metabolic Syndrome in the elderly

S. Maggi (Italy)

03:30 p.m.

04:00 p.m.

Coffee Break

04:00 p.m.

05:00 p.m.

•

•

•

•

Oral communications selected from abstracts

& REWARD

Chair : P. Duriez (France)

A Novel APOA5 Missense Mutation Associated

With Chylomicronemia Sensitive to Fibrate Therapy

P. Benlian (France)

Western Diet Affects Liver and Urinary Steroids in CYP27A1 Deficient Mice

G. Escher (Suisse)

FABP2 Ala54Thr polymorphism and metabolic syndrome components in Caribbean Type 2 Diabetic Subjects

M.O Joannes (Guyane)

A common variant in the FTO gene is associated with BMI

in a central european population - the HAPIEE study

J.A. Hubacek (Czech Republic)